Institutional Research Archive

Hedge Fund Letters Archive

Browse the world's most comprehensive database of hedge fund investor letters, sorted by recent quarter. Access primary source research from leading institutional managers.

Quarter	Letter Date	Fund Name	QTD	YTD	Tickers	Themes	Quick Take

Home Letters Funds Account

Conestoga SMid Cap Composite 2024 Q2 Investor Letter | Buyside Digest

Back to Fund Profile (Conestoga SMid Cap Composite)

Primary Source Intelligence • Q2 2024 Letter Analysis

Conestoga SMid Cap Composite Quarterly Analysis

Buyside Digest is not affiliated with, and does not endorse, Conestoga SMid Cap Composite. This analysis is provided for institutional research purposes only and is not investment advice.

Fund Returns

Annualized+9.03%

Digest Analysis

Quick Take

"Conestoga's SMid Cap strategy underperformed slightly in Q2 as Health Care and Consumer Discretionary holdings faced sector-specific headwinds while Technology software names outperformed."

Executive Summary

Conestoga's SMid Cap Composite declined -4.82% in Q2 2024, slightly underperforming the Russell 2500 Growth Index return of -4.22%. The portfolio faced headwinds from stock selection in Health Care and Consumer Discretionary sectors, partially offset by strong performance in Technology and Industrials. Health Care challenges centered on Stevanato Group's guidance reduction due to vial destocking and Repligen's earnings miss despite revenue beats. Consumer discretionary names tied to residential repair and remodel spending struggled, with SiteOne Landscape Supply and Pool Corp citing weaker discretionary spending. Technology sector strength came from software holdings that outperformed despite industry headwinds, led by Tyler Technologies reaching new highs and Guidewire Software's strong subscription growth acceleration. The manager added SPX Technologies as a durable infrastructure equipment business while selling Definitive Healthcare due to execution issues and management instability. Despite current small cap underperformance, Conestoga maintains confidence in their high-quality portfolio's long-term outperformance potential.

Unlock Full Institutional Analysis

Sign in or create a free account to unlock full commentary, extracted equity pitches, and direct outbound manager source links with your 3 quarterly credits.

Sign In to Unlock (3 Free Credits)View Pricing Tiers

Institutional Meta Strategy

Meta Strategy Gauges

Algorithmic conviction, macroeconomic posture, and risk appetite signals extracted from this quarterly letter with qualitative explanations.

Signal Matrix

Market Conviction

65%

CautiousHigh

Moderate (65%)

Moderate-high conviction evidenced by concentrated portfolio with 40-60 holdings, specific position sizing discussions, and clear thesis-driven buying and selling decisions including adding SPX Technologies and selling Definitive Healthcare.

Growth Outlook

38%

BearishBullish

Neutral (38%)

The manager expresses caution about current market conditions with small caps underperforming and specific sector headwinds, but maintains long-term optimism about their positioning.

Risk Appetite

10%

DefensiveAggressive

Defensive (10%)

Portfolio remains fully invested with selective additions and sales, showing measured risk appetite despite market challenges.

Capital Deployment

5%

De-riskingDeploying

De-risking (5%)

Limited net deployment activity with one new addition and one sale, representing rotation rather than significant capital deployment or withdrawal.

Forward Guidance

25%

CautiousExpansionary

Cautious (25%)

Manager expresses confidence in long-term positioning and expects their high-quality portfolios to deliver outperformance over time.

Language Signal

45%

BearishBullish

Balanced (45%)

Language balances challenges and headwinds with confidence in positioning, with slightly more cautious than bullish directional language.

Perceived Risk

45%

Low RiskElevated

Moderate Risk (45%)

Manager acknowledges sector-specific risks and small cap underperformance but does not express systemic concerns, focusing on company-specific execution issues.

Opportunity Density

55%

ScarceAbundant

Selective (55%)

Manager sees selective opportunities as evidenced by adding SPX Technologies while maintaining confidence in existing holdings despite current headwinds.

Time Horizon

70%

Short-TermLong-Term

Decade+ (70%)

Clear long-term orientation with emphasis on positioning portfolios for long-term capital appreciation and maintaining conviction through short-term volatility.